The Discounted Cash Flow (DCF) valuation of Solasia Pharma KK (4597.T) is (4,219.71) JPY. With the latest stock price at 25.00 JPY, the upside of Solasia Pharma KK based on DCF is -16978.8%.
Based on the latest price of 25.00 JPY and our DCF valuation, Solasia Pharma KK (4597.T) is a sell. selling 4597.T stocks now will result in a potential gain of 16978.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 6.9% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (27,523.65) - (2,304.33) | (4,219.71) |
| Upside | -110194.6% - -9317.3% | -16978.8% |